The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ASTRIA THERAPEUTICS INC | COM | 04635X102 | 2,115 | 239,270 | SH | SOLE | 0 | 239,270 | 0 | 0 | |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 39,425 | 2,190,291 | SH | SOLE | 0 | 2,190,291 | 0 | 0 | |
| BCLS ACQUISITION CORP | COM CL A | G0904B105 | 2,490 | 250,000 | SH | SOLE | 0 | 250,000 | 0 | 0 | |
| C4 THERAPEUTICS INC | COM STK | 12529R107 | 21,495 | 481,094 | SH | SOLE | 0 | 481,094 | 0 | 0 | |
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 16,084 | 1,912,511 | SH | SOLE | 0 | 1,912,511 | 0 | 0 | |
| CELCUITY INC | COM | 15102K100 | 16,568 | 920,464 | SH | SOLE | 0 | 920,464 | 0 | 0 | |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 13,401 | 248,207 | SH | SOLE | 0 | 248,207 | 0 | 0 | |
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 15,220 | 4,169,896 | SH | SOLE | 0 | 4,169,896 | 0 | 0 | |
| CYTOKINETICS INC | COM NEW | 23282W605 | 28,470 | 796,578 | SH | SOLE | 0 | 796,578 | 0 | 0 | |
| DICERNA PHARMACEUTICALS INC | COM | 253031108 | 26,052 | 1,292,251 | SH | SOLE | 0 | 1,292,251 | 0 | 0 | |
| DYNE THERAPEUTICS INC | COM | 26818M108 | 4,955 | 305,125 | SH | SOLE | 0 | 305,125 | 0 | 0 | |
| GENOCEA BIOSCIENCES INC | COM NEW | 372427401 | 5,913 | 3,079,756 | SH | SOLE | 0 | 3,079,756 | 0 | 0 | |
| IVERIC BIO INC | COM | 46583P102 | 44,662 | 2,750,137 | SH | SOLE | 0 | 2,750,137 | 0 | 0 | |
| INVENTIVA SA | ADS | 46124U107 | 3,719 | 262,658 | SH | SOLE | 0 | 262,658 | 0 | 0 | |
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 8,948 | 362,869 | SH | SOLE | 0 | 362,869 | 0 | 0 | |
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 5,454 | 312,553 | SH | SOLE | 0 | 312,553 | 0 | 0 | |
| KRONOS BIO INC | COM | 50107A104 | 6,264 | 298,839 | SH | SOLE | 0 | 298,839 | 0 | 0 | |
| KURA ONCOLOGY INC | COM | 50127T109 | 18,719 | 999,433 | SH | SOLE | 0 | 999,433 | 0 | 0 | |
| MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 4,775 | 1,972,958 | SH | SOLE | 0 | 1,972,958 | 0 | 0 | |
| MERUS N V | COM | N5749R100 | 15,799 | 718,136 | SH | SOLE | 0 | 718,136 | 0 | 0 | |
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 3,725 | 125,000 | SH | SOLE | 0 | 125,000 | 0 | 0 | |
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 8,826 | 498,079 | SH | SOLE | 0 | 498,079 | 0 | 0 | |
| REVOLUTION MEDICINES INC | COM | 76155X100 | 6,224 | 226,228 | SH | SOLE | 0 | 226,228 | 0 | 0 | |
| SATSUMA PHARMACEUTICALS INC | COM | 80405P107 | 14,533 | 3,118,761 | SH | SOLE | 0 | 3,118,761 | 0 | 0 | |
| SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 969 | 97,143 | SH | SOLE | 0 | 97,143 | 0 | 0 | |
| TENAYA THERAPEUTICS INC | COM | 87990A106 | 10,613 | 513,930 | SH | SOLE | 0 | 513,930 | 0 | 0 | |
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 10,983 | 667,674 | SH | SOLE | 0 | 667,674 | 0 | 0 | |
| VISTAGEN THERAPEUTICS INC | COM NEW | 92840H202 | 14,038 | 5,123,509 | SH | SOLE | 0 | 5,123,509 | 0 | 0 | |
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 8,854 | 579,432 | SH | SOLE | 0 | 579,432 | 0 | 0 | |